Clinical and Experimental Vaccine Research

The Korean Vaccine Society (대한백신학회)
권호 표지
DOI QR코드

DOI QR Code

Evaluating the knowledge, attitude, perception, and readiness of caregivers of under 5-year-old children to accept malaria vaccine in Nigeria

  • Blessing Nkechi Emmanuel (Department of Zoology, Faculty of Life Sciences, Modibbo Adama University of Technology) ;
  • Abubakar Nuhu Ishaq (Department of Biology, Faculty of Life Sciences, Ahmadu Bello University) ;
  • Olisaemeka Zikora Akunne (Department of Pharmacy, Faculty of Pharmaceutical Science, University of Nigeria Nsukka) ;
  • Umar Faruk Saidu (Department of Biochemistry and Molecular Biology, Faculty of Life Sciences, Usmanu Danfodiyo University)
  • Received : 2023.07.25
  • Accepted : 2024.03.28
  • Published : 2024.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: The global burden of disease and mortality is greatly influenced by malaria, particularly in children. Nigeria alone accounts for about 25% of global malaria cases and fatalities. Despite efforts to control and eliminate malaria, conventional treatments have limitations, prompting the need for a vaccine. However, while efforts have focused on researching and developing malaria vaccines, less attention has been given to public acceptance and preparedness for vaccination. Materials and Methods: The study employed a cross-sectional approach to assess the knowledge, perceptions, and readiness of caregivers towards the malaria vaccine. Data were collected through a physical and online survey among a representative sample of caregivers across the six geopolitical regions of Nigeria. The data was analyzed using principal component analysis and percentages. Results: Out of 347 respondents, 180 (51%) men, 165 (46.6%) women, 2 (0.5%) transgender, 156 (45%) rural settlers, and 191 (55%) urban settlers were identified in this study. The study reported an overall acceptance rate of 78.4% and 21.6% resistance rate. The age group between 21-30 years recorded the highest 207 (59.6%). A significant number of participants, 252 (59.6%), held at least a higher or post-secondary certificate, out of which 193 (55.6%) demonstrated strong readiness to accept the malaria vaccine. The study showed that fear of adverse effects was the main reason for malaria vaccine resistance among caregivers. Conclusion: This study's findings offer valuable insights into caregivers' knowledge about the malaria vaccine, highlighting the factors that impact the acceptance of the malaria vaccine.

Keywords

Acknowledgement

The authors of this study would like to appreciate all the caregivers who participated in this study.

References

  1. World Health Organization. Fact sheets: malaria [Internet]. Geneva: World Health Organization; 2023 [cited 2023 Jul 10]. Available from: https://www.who.int/health-topics/malaria#tab=tab_1
  2. World Health Organization. WHO calls for reinvigorated action to fight malaria: global malaria gains threatened by access gaps, COVID-19 and funding shortfalls? [Internet]. Geneva: World Health Organization; 2020 [cited 2023 Jul 10]. Available from: https://www.who.int/news/item/30-11-2020-who-calls-for-reinvigorated-action-to-fight-malaria
  3. Thu AM, Phyo AP, Landier J, Parker DM, Nosten FH. Combating multidrug-resistant Plasmodium falciparum malaria. FEBS J 2017;284:2569-78.
  4. World Health Organization. Ten years in public health, 2007-2017: report by Dr. Margaret chan, director-general, world health organization [Internet]. Geneva: World Health Organization; 2017 [cited 2023 Jul 10]. Available from: https://apps.who.int/iris/handle/10665/255355
  5. Schuchat A. Human vaccines and their importance to public health. Procedia Vaccinol 2011;5:120-6.
  6. United Nations Sustainable Development Goals Knowledge Platform. Sustainable development goal (SDG) 3; good health and well being [Internet]. New York (NY): United Nations; 2023 [cited 2023 Jul 10]. Available from: https://www.jointsdgfund.org/sustainable-development-goals/goal-3-good-health-and-well-being#:-:text=SDG%203%20aspires%20to%20ensure,medicines%20and%20vaccines%20for%20all
  7. RTS,S Clinical Trials Partnership. Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites. PLoS Med 2014;11:e1001685.
  8. Aremu TO, Ajibola OA, Oluwole OE, Adeyinka KO, Dada SO, Okoro ON. Looking beyond the malaria vaccine approval to acceptance and adoption in Sub-Saharan Africa. Front Trop Dis 2022;3:857844.
  9. World Health Organization. World malaria day 2023 [Internet]. Geneva: World Health Organization; 2023 [cited 2023 Jul 10]. Available from: https://www.who.int/westernpacific/news-room/events/detail/2023/04/25/western-pacific-events/world-malaria-day-2023#:-:text=World%20Malaria%20Day%202023%20will,unreached%across%20the%20Western%20Pacific
  10. World Health Organization. WHO recommends ground-breaking malaria vaccine for children at risk; historic RTS,S/AS01 recommendation can reinvigorate the fight against malaria [Internet]. Geneva: World Health Organization; 2021 [cited 2023 Jul 10]. Available from: https://www.who.int/news/item/06-10-2021-who-recommends-ground-breaking-malaria-vaccine-for-children-at-risk
  11. Jegede AS. What led to the Nigerian boycott of the polio vaccination campaign? PLoS Med 2007;4:e73.
  12. Seyi-Olajide JO, Ameh EA. Investing in pediatric surgical research to advance universal health coverage for children in Nigeria. Niger J Surg 2020;26:1-8.
  13. Ighalo JO, Adeniyi AG. A comprehensive review of water quality monitoring and assessment in Nigeria. Chemosphere 2020;260:127569.
  14. Schrier K, Ohu E, Bodunde I, Alugo M, Emami C, Babatunde A. Piloting a game jam in nigeria to support empathy and compassion. Proceedings of the 6th Annual International Conference on Game Jams, Hackathons, and Game Creation Events; 2021 Aug 2; Montreal, Canada. New York (NY): Association for Computing Machinery; 2021. p. 60-3.
  15. Jung SH. Stratified Fisher's exact test and its sample size calculation. Biom J 2014;56:129-40.
  16. Asmare G. Willingness to accept malaria vaccine among caregivers of under-5 children in southwest ethiopia: a community based cross-sectional study. Malar J 2022;21:146.
  17. Stratton SJ. Population research: convenience sampling strategies. Prehosp Disaster Med 2021;36:373-4.
  18. Birkett AJ. PATH Malaria Vaccine Initiative (MVI): perspectives on the status of malaria vaccine development. Hum Vaccin 2010;6:139-45.
  19. Ojakaa DI, Jarvis JD, Matilu MI, Thiam S. Acceptance of a malaria vaccine by caregivers of sick children in Kenya. Malar J 2014;13:172.
  20. Mtenga S, Kimweri A, Romore I, et al. Stakeholders' opinions and questions regarding the anticipated malaria vaccine in Tanzania. Malar J 2016;15:189.
  21. McCoy KD, Weldon CT, Ansumana R, et al. Are malaria transmission-blocking vaccines acceptable to high burden communities?: results from a mixed methods study in Bo, Sierra Leone. Malar J 2021;20:183.
  22. World Health Organization. Malaria: the malaria vaccine implementation programme (MVIP) [Internet]. Geneva: World Health Organization; 2020 [cited 2023 Jul 10]. Available from: https://www.who.int/news-room/questions-and-answers/item/malaria-vaccine-implementation-programme
  23. Smith LE, Amlot R, Weinman J, Yiend J, Rubin GJ. A systematic review of factors affecting vaccine uptake in young children. Vaccine 2017;35:6059-69.
  24. Larson HJ, Clarke RM, Jarrett C, et al. Measuring trust in vaccination: a systematic review. Hum Vaccin Immunother 2018;14:1599-609.
  25. Goldman RD, Yan TD, Seiler M, et al. Caregiver willingness to vaccinate their children against COVID-19: cross sectional survey. Vaccine 2020;38:7668-73.
  26. Russo G, Miglietta A, Pezzotti P, et al. Vaccine coverage and determinants of incomplete vaccination in children aged 12-23 months in Dschang, West Region, Cameroon: a cross-sectional survey during a polio outbreak. BMC Public Health 2015;15:630.
  27. Tabiri D, Ouedraogo JC, Nortey PA. Factors associated with malaria vaccine uptake in Sunyani Municipality, Ghana. Malar J 2021;20:325.
  28. Gachelin G, Garner P, Ferroni E, Verhave JP, Opinel A. Evidence and strategies for malaria prevention and control: a historical analysis. Malar J 2018;17:96.
  29. Kuroda H, Goto A, Kawakami C, Yamamoto K, Ito S; Japan Environment and Children's Study (JECS) Group. Association between a single mother family and childhood undervaccination, and mediating effect of household income: a nationwide, prospective birth cohort from the Japan Environment and Children's Study (JECS). BMC Public Health 2022;22:117.
  30. Decouttere C, De Boeck K, Vandaele N. Advancing sustainable development goals through immunization: a literature review. Global Health 2021;17:95.
  31. Wemakor A, Helegbe GK, Abdul-Mumin A, Amedoe S, Zoku JA, Dufie AI. Prevalence and factors associated with incomplete immunization of children (12-23 months) in Kwabre East District, Ashanti Region, Ghana. Arch Public Health 2018;76:67.
  32. Marskole P, Rawat R, Chouhan P, Sahu P, Choudhary R. Knowledge, attitude, and practices on vaccination among mothers of under-5 children, attending immunization out patient department of Gwalior, Madhya Pradesh. Int J Sci Study 2016;3:235-7.
  33. Dawar M, Dobson S, Kallos A, LaJeunesse C, Weatherill S, Daly P. Measuring hepatitis B uptake in a new universal infant program. Can J Public Health 2002;93:281-4.
  34. Whiting CM, Schabas RE, Ashley MJ. Hib vaccine coverage in children attending day care/nursery school in East York. Can J Public Health 1990;81:152-5.
  35. Kaur B. Attitudes, risks and norms: understanding parents' measles-mumps-rubella (MMR) immunisation decision-making [dissertation]. Stirling: University of Stirling; 2011.
  36. Bedford H. Achieving immunisation targets: the health visitor's role. Health Visit 1990;63:416-8.
  37. Bults M, Beaujean DJ, Richardus JH, van Steenbergen JE, Voeten HA. Pandemic influenza a (H1N1) vaccination in the netherlands: parental reasoning underlying child vaccination choices. Vaccine 2011;29:6226-35.